Evidence map›Paper›PMID 20110692›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2010

Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes.

Mona M Mohamed, Dora Cavallo-Medved, Deborah Rudy, Arulselvi Anbalagan, Kamiar Moin, Bonnie F Sloane

Open access · bronzeAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Helicobacter pylori and gastric cancer: a lysosomal protease perspective.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Non-invasiveTheranostics · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Pericellular proteolysis in cancer.Genes & development · 2014
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mona M MohamedDepartment of Zoology, Faculty of Science, Cairo University, Giza, Egypt. monamos@link.net
Dora Cavallo-Medved
Deborah Rudy
Arulselvi Anbalagan
Kamiar Moin
Bonnie F Sloane
The Barbara Ann Karmanos Cancer Institute · USCairo University · EGWayne State University · US

Funding

CATHEPSINS IN MALIGNANT PROGRESSION OF MCF 10R01CA056586 · NCI · WAYNE STATE UNIVERSITY · PI SLOANE, BONNIE F · 1992 to 2009
$3.3M
Proteolytic Pathways in Progression of Pre-Malignant Breast DiseaseR01CA131990 · NCI · WAYNE STATE UNIVERSITY · PI MATTINGLY, RAYMOND R, SLOANE, BONNIE F · 2008 to 2013
$1.9M
NCI NIH HHS CA 56586NCI NIH HHS R01 CA056586NCI NIH HHS R01 CA131990
6 · The paper itself

Abstract

In the tumor microenvironment, monocytes respond to paracrine stimuli from breast cancer cells by secreting molecules that participate in breast cancer growth, invasion, intravasation and metastasis. Here we examined the effects of media conditioned by MDA-MB-231 human breast carcinoma cells (231-CM) on expression and secretion of proteases and secretion of cytokines by U937 human monocytes. We found that 231-CM increased U937: 1) proliferation; 2) expression, activity and secretion of the cysteine protease cathepsin B (CTSB); 3) secretion of matrix metalloproteinases (MMP)-2 and -9; and 4) secretion of interleukin-6 (IL-6) and insulin-like growth factor binding protein-1 (IGFBP-1). We further demonstrated by western blotting and enzymatic activity assays that the increases in CTSB secretion and activity induced by 231-CM could be reduced by neutralizing antibodies against IL-6. Our data suggest a role for IL-6 in increased monocyte expression and secretion of CTSB in response to soluble factors secreted by breast cancer cells.

Indexed as

Breast NeoplasmsCathepsin BCell Line, TumorCell ProliferationFemaleHumansInsulin-Like Growth Factor Binding Protein 1Interleukin-6Matrix Metalloproteinase 2Matrix Metalloproteinase 9MonocytesCathepsin BInsulin-Like Growth Factor Binding Protein 1Interleukin-6Matrix Metalloproteinase 2Matrix Metalloproteinase 9

Identifiers

PMID20110692
PMCPMC3030463
OpenAlexW2035974720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.